Staying ahead of the curve in HNSCC care: Refining the role of immunotherapy across disease stages
touchEXPERT FOCUS for touchONCOLOGY
Listen to insights from Prof. Jean-Pascal Machiels on optimizing the use of immunotherapy in patients with recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) and the potential future role of immunotherapy in resectable locally advanced HNSCC.
The expert:
Prof. Jean-Pascal Machiels, Cliniques universitaires Saint-Luc, Brussels, Belgium
This touchPODCAST is for HCPs outside of the UK.
This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC.
The activity is jointly provided by USF Health and touchIME…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.